Deal Making in Oncology




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Deal Making in Oncology
Released on: September 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    This month's business report looks at trends in deal making within the oncology sector.
  • Summary
  • Transcript
  • Company
This month's business report looks at trends in deal making within the oncology sector. Using data from PharmaVentures' proprietary deal information resource, PharmaDeals® Agreements, we take a look at changes in the number and type of oncology deals that have been signed since 2000. We then focus on licensing deals and investigate the trends in the types of company, product and phase of development and identify which are the most prolific deal making companies in this sector. We also discuss the relative attrition rates for products in this field of therapeutic medicine.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK